LONDON, Jan 28 (Reuters) – The Trump administration has told global vaccine group Gavi to phase out shots containing the preservative thimerosal as a condition of providing the group with funding, a U.S. official and a Gavi spokesperson told Reuters. Read full story
Exclusive-US conditions funding to global vaccine group on dropping mercury-based preservative from shots
